×
Back to Agenda
Session 1: Setting up the Scene: More than 10 Years of ATMPs in Europe
Session Chair(s)
Jacquelyn Awigena-Cook, MSc
Director, Global Regulatory Policy & Intelligence, Bristol Myers Squibb, United Kingdom
Topics covered in this session include:
- The inclusion of Innovation Therapies in the Pharma Strategy
- The last 10 years of Innovative Therapies in the EU
- Complexities in cell and gene therapies development: how have we accommodated them in our reimbursement systems.
Speaker(s)
Emil Andrei Cochino, MD, MHS
Scientific Senior Specialist (Risk Management), European Medicines Agency, Netherlands
Reflections from the Various Stakeholders
Anne Kerber
SVP Head of Cell Therapy Development , Bristol Myers Squibb , Germany
Antonella Cardone
Director, Cancer Patients Europe, Belgium
François Houyez
Treatment Information and Access Director, Health Policy Advisor, European Organisation for Rare Diseases (EURORDIS), France
Have an account?